Thank you for your interest in the EFZO-FIT™ study.

This study is no longer enrolling new patients.

EFZO-FIT™ in a clinical study for patients with Pulmonary Sarcoidosis to see if an investigational treatment called Efzofitimod will allow people to reduce their steroid dose while maintaining symptom control and preserving lung function.

For updates on the study, please visit www.atyrpharma.com.